NCT06887608

Brief Summary

The World Health Organization (WHO) recommends the use of non-pharmacological methods for the relief of labor pain. The use of non-pharmacological methods in pain management helps women see their labor as a natural event and contributes to the reduction of cesarean section rates by increasing satisfaction with normal birth . The rebozo technique, a traditional method, originates from Latin America and is a non-invasive, non-drug practical application. The rebozo technique reduces or eliminates pain by creating rhythmic movements in the pelvic area. No study has been found evaluating the results of partner-assisted rebozo application in the intrapartum period. For this reason, it is important to conduct evidence-based studies examining the effects of the use of rebozo technique in labor. This randomized controlled study will contribute to the literature. For this purpose, this study was planned to examine the effects of partner-assisted rebozo application in the intrapartum period on fear of labor, pain, and labor satisfaction.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jul 2025Sep 2026

First Submitted

Initial submission to the registry

March 16, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 20, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

July 22, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2026

Expected
Last Updated

July 25, 2025

Status Verified

June 1, 2025

Enrollment Period

10 months

First QC Date

March 16, 2025

Last Update Submit

July 22, 2025

Conditions

Keywords

birth, rebozo, fear of birth, birth pain, satisfaction

Outcome Measures

Primary Outcomes (3)

  • Visual analog scale (VAS)

    Visual analog scale (VAS): The pain levels of the participants will be evaluated with the Visual analog scale (VAS). It was developed by Bond and Pilowski in 1966 in order to describe the severity of pain in individuals numerically. This measurement tool is a 10 cm long ruler. While the expression "no pain" is written on the left end, the expression "unbearable pain" is written on the right end. Since it has linear properties, the difference between each increase is equal. It is the most commonly used single-dimensional scale type because it does not guide individuals with numbers due to its usage feature, the evaluation is easy and fast, and it gives results in a short time. A VAS value approaching 10 indicates that the pain is very severe, while a value approaching 0 is evaluated as the pain has decreased.

    8 hours

  • Birth Satisfaction Scale:

    Birth Satisfaction Scale: Participants' satisfaction levels will be assessed with the Birth Satisfaction Scale. The scale, which was developed to assess women's perceptions of birth, was developed by Martin and Fleming in 2009. Its Turkish validity and reliability were made by Çoşar Çetin and colleagues in 2015. The scale is Likert-type and is scored from 5 (Strongly agree) to 1 (Strongly disagree). Items 4, 8, 12, 15, 16, 17, 19, 20, 21, 23, 25, and 29 are scored reversely. The scale has 30 items and the possible score varies between 30-150. There is no cut-off point for the scale. As the score increases, satisfaction with birth increases. The scale has 3 sub-dimensions: Quality of care (home assessment, birth environment, adequate support and communication with healthcare personnel), personal characteristics of women (ability to cope with birth, sense of control, preparation for birth, communication with the baby), and stress experienced during the birth process (experiencing distre

    8 hours

  • Fear of Childbirth Scale:

    Fear of Childbirth Scale: Participants' fear levels will be assessed with the Fear of Childbirth Scale. The scale measures fear during childbirth. The scale, developed by Wijma et al. (2002), was validated in Turkish by Serçekuş et al. in 2017 for validity and reliability. The scale measuring fear during childbirth consists of 10 items. The scale takes 30-90 seconds to administer. Each item in the scale is asked to be scored from 1 (completely disagree) to 10 (completely agree). The possible scores from the scale are between 10-100. A high score indicates high fear. It is an extremely practical scale in terms of application. 5 items (1,3,5,7,10) in the scale are positive and 5 items (2,4,6,8,9) are negative. The 5 items with positive meanings on the scale are reverse scored. The scale can be applied to all multiparous and primiparous women who are admitted to the delivery room and have cervical dilatation of 3 cm or more. The Cronbach alpha reliability coefficient of the scale is 0.88

    8 hours

Study Arms (3)

husband supported rebozo group

EXPERIMENTAL

In the partner-assisted rebozo group, information will be provided to the partner and the pregnant woman with the education booklet created during the latent phase and training will be provided. When the pregnant woman reaches 4-5 cm, 6-7 cm and 8-9 cm vaginal dilation, the data collection forms and scale forms determined for the pregnant woman in the partner-assisted rebozo group will be filled in before the rebozo application. Rebozo application will be applied to the pregnant woman for three contractions. A re-evaluation will be made after the rebozo application. The determined scales will be applied at the 4th hour in the postpartum period.

Other: Husband assisted rebozo application

midwife assisted rebozo group

EXPERIMENTAL

In the midwife-assisted rebozo group, information will be provided to the pregnant woman with the education booklet created during the latent phase and training will be provided. When the pregnant woman reaches 4-5 cm, 6-7 cm and 8-9 cm vaginal dilation, the data collection forms and scale forms determined for the pregnant woman in the midwife-assisted rebozo group will be filled in before the rebozo application. Rebozo application will be applied to the pregnant woman for three contractions. A re-evaluation will be made after the rebozo application. The determined scales will be applied at the 4th hour in the postpartum period.

Other: Midwife assisted rebozo application

control group

NO INTERVENTION

In the control group, when the pregnant woman reaches 4-5 cm, 6-7 cm and 8-9 cm vaginal opening, the same measurements will be made and the woman will continue to receive routine care, and then the measurements will be repeated. In the 4th hour after birth, the determined scales will be applied.

Interventions

At 4-5 cm, 6-7 cm and 8-9 cm, the pregnant woman will be given a rebozo by her husband.

husband supported rebozo group

The midwife will apply rebozo to the pregnant woman at 4-5 cm, 6-7 cm and 8-9 cm.

midwife assisted rebozo group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen who are coming to birth and are 4-5 cm dilated in their first pregnancy
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being literate,
  • Knowing Turkish,
  • Being over 18 years of age,
  • Being primiparous,
  • Having a single fetus and cephalic presentation,
  • Being at term (37-42 weeks),
  • Not having risk factors during pregnancy (Preeclampsia, premature rupture of membranes, oligohydramnios and polyhydramnios, gestational diabetes, placental anomalies, intrauterine growth retardation, intrauterine dead fetus, fetal distress, macrosomic babies, etc.),
  • Being in the active phase of the first stage of labor,
  • Those who agree to participate in the research,
  • The spouse also agrees to participate in the research.

You may not qualify if:

  • Being multiparous,
  • Having multiple pregnancies,
  • Women with any chronic disease,
  • Women with a diagnosed psychiatric disease,
  • Pregnant women with spine and bone structure problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Training and Research Hospital

Zeytinburnu, Istanbul, 34020, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Personal Satisfaction

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • DİLAN C Phd Candidate

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
In order to increase the reliability of the research and to distribute the groups homogeneously, groups will be assigned from the website www.randomizer.org. Pregnant women belonging to all three groups will be assigned to the groups through this website.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: It was designed as a randomized controlled experimental study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Phd Candidate

Study Record Dates

First Submitted

March 16, 2025

First Posted

March 20, 2025

Study Start

July 22, 2025

Primary Completion

May 20, 2026

Study Completion (Estimated)

September 15, 2026

Last Updated

July 25, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations